Novozymes A/S
NVZMY · OTC
Bulios Fair Price
$44.85
33.7% downside
Current Price
$67.64
According to Bulios Fair Price, NVZMY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Novozymes A/S is a Danish biotechnology company founded in 2000 and headquartered in Bagsværd, Denmark. The company is a leader in the development and production of industrial enzymes and microorganisms, which are used in a wide range of industries, including food, agriculture, textiles, biofuels, and wastewater treatment. Novozymes focuses on sustainability and innovation, with its products helping to increase manufacturing efficiency, reduce environmental impact, and support the transition to a more sustainable economy. The company operates globally, with its products distributed to over 130 countries.
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Ester Baiget
Employees
11,641
Headquarters
Lyngby
Upcoming events
Earnings
Upcoming earnings report